India business is expected to grow 10 to 12 percent YoY, driven by volume gains, in-licensing deals, and new launches.

Sun Pharmaceutical Industries Ltd. closed 11.49% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

The BSE Sensex rose 143.91 points, or 0.18 per cent, to close at 81,481.86. The NSE Nifty50 gained 33.95 points, or 0.14 per ...

This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Aurobindo Pharma, Sun Pharma, Maruti ...

Markets end flat amid F&O expiry and Fed jitters; L&T gains 4.7% post Q1 results. Rupee breaches 87.40/USD; Nifty holds above ...

Key Takeaways Nifty ended at 24,865.60, up 44.50 points, with Sensex gaining 172.31 points to trade at Rs. 81,510.26 amid ...

AMERICAN patients will pay the cost of Donald Trump’s 15 per cent tariffs on Europe’s pharmaceutical industry, an Irish ...

Of the 50 stocks on the blue-chip Nifty, 22 advanced. The market capitalisation jumped by nearly Rs 13,000 lakh crore.

Two diabetes drugs could become more affordable for Maryland residents, following a study by the Prescription Drug ...

Rocket Lab's stock has skyrocketed over the past year. The company is launching more rockets and gaining new contracts. The ...

Ahmedabad: Zydus Lifesciences Limited has announced the completion of the acquisition of an 85.6 percent stake in Amplitude ...